{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:33:26Z","timestamp":1768433606598,"version":"3.49.0"},"reference-count":28,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.2967\/jnumed.117.201632","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T19:50:22Z","timestamp":1517514622000},"page":"960-966","source":"Crossref","is-referenced-by-count":78,"title":["Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models"],"prefix":"10.2967","volume":"59","author":[{"given":"Ruiqing","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruhiko","family":"Sahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichio","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agneta","family":"Nordberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Suhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"2021051712120590000_59.6.960.1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.24.1.1121"},{"key":"2021051712120590000_59.6.960.2","doi-asserted-by":"publisher","DOI":"10.1385\/NMM:2:2:131"},{"key":"2021051712120590000_59.6.960.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70156-9"},{"key":"2021051712120590000_59.6.960.4","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e31825018f7"},{"key":"2021051712120590000_59.6.960.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.06.006"},{"key":"2021051712120590000_59.6.960.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70252-2"},{"key":"2021051712120590000_59.6.960.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.07.037"},{"key":"2021051712120590000_59.6.960.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.117341"},{"key":"2021051712120590000_59.6.960.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.164848"},{"key":"2021051712120590000_59.6.960.10","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-122059"},{"key":"2021051712120590000_59.6.960.11","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-130098"},{"key":"2021051712120590000_59.6.960.12","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24546"},{"key":"2021051712120590000_59.6.960.13","first-page":"764","article-title":"Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies","volume":"140","author":"Ono","year":"2017","journal-title":"Brain."},{"key":"2021051712120590000_59.6.960.14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.24844","article-title":"Pathological correlations of [F-18]-AV-1451 imaging in non-Alzheimer tauopathies","volume":"81","author":"Marqui\u00e9","year":"2017","journal-title":"Ann Neurol."},{"key":"2021051712120590000_59.6.960.15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/mds.26727","article-title":"Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy","volume":"32","author":"Hammes","year":"2017","journal-title":"Mov Disord."},{"key":"2021051712120590000_59.6.960.16","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1177\/0271678X16683695","article-title":"Positron emission tomography imaging of tau pathology in progressive supranuclear palsy","volume":"37","author":"Coakeley","year":"2017","journal-title":"J Cereb Blood Flow Metab."},{"key":"2021051712120590000_59.6.960.17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/ene.13164","article-title":"Tau imaging with [18F]THK-5351 in progressive supranuclear palsy","volume":"24","author":"Ishiki","year":"2017","journal-title":"Eur J Neurol."},{"key":"2021051712120590000_59.6.960.18","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201105493"},{"key":"2021051712120590000_59.6.960.19","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt231"},{"key":"2021051712120590000_59.6.960.20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1113694"},{"key":"2021051712120590000_59.6.960.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.01.010"},{"key":"2021051712120590000_59.6.960.22","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2312-08.2008"},{"key":"2021051712120590000_59.6.960.23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3076-10.2011"},{"key":"2021051712120590000_59.6.960.24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24517"},{"key":"2021051712120590000_59.6.960.25","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.3233\/JAD-132429","article-title":"Tau oligomers as potential targets for early diagnosis of tauopathy","volume":"40","author":"Sahara","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"2021051712120590000_59.6.960.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2016.12.009"},{"key":"2021051712120590000_59.6.960.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.163493"},{"key":"2021051712120590000_59.6.960.28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain","volume":"9","author":"Ng","year":"2017","journal-title":"Alzheimers Res Ther."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.117.201632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:27:37Z","timestamp":1621283257000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.117.201632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,1]]},"published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.2967\/jnumed.117.201632"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.117.201632","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,1]]}}}